Media

@article{Rabinowitz2023,

title = {Patterns of demoralization and anhedonia during early substance use disorder treatment and associations with treatment attrition},

author = {Jill A. Rabinowitz and Jennifer D. Ellis and Justin C. Strickland and Martin Hochheimer and Yijun Zhou and Andrea S. Young and Brenda Curtis and Andrew S. Huhn},

doi = {10.1016/j.jad.2023.05.029},

issn = {0165-0327},

year  = {2023},

date = {2023-08-00},

journal = {Journal of Affective Disorders},

volume = {335},

pages = {248--255},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023d,

title = {Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder},

author = {Jennifer D. Ellis and Jamey J. Lister and Michael J.A. Wohl and Mark K. Greenwald and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2022.107604},

issn = {0306-4603},

year  = {2023},

date = {2023-05-00},

journal = {Addictive Behaviors},

volume = {140},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2022b,

title = {Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use},

author = {Jennifer D. Ellis and Jill A. Rabinowitz and Jonathan Wells and Fangyu Liu and Patrick H. Finan and Michael D. Stein and Denis G. Antoine II and Gregory J. Hobelmann and Andrew S. Huhn},

doi = {10.1016/j.jad.2021.12.004},

issn = {0165-0327},

year  = {2022},

date = {2022-02-00},

journal = {Journal of Affective Disorders},

volume = {299},

pages = {223--232},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021b,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021c,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2021,

title = {Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies},

author = {Meagan M. Carr and Jennifer D. Ellis and Karen K. Saules and Jamie L. Page and Angela Staples and David M. Ledgerwood},

doi = {10.1111/ajad.13149},

issn = {1521-0391},

year  = {2021},

date = {2021-07-00},

journal = {American J Addict},

volume = {30},

number = {4},

pages = {343--350},

publisher = {Wiley},

abstract = {Background and ObjectivesPatients receiving opioid agonist therapies have high rates of psychiatric comorbidity. Some data suggest that comorbidity is associated with poorer treatment outcomes. The current study assessed predictors of multiple putative addictive behaviors among patients receiving opioid agonist therapies.MethodsAdults (N = 176) recruited from an outpatient clinic providing opioid agonist therapy completed self‐report measures of depression, anxiety, impulsivity, adverse childhood events, and the Recognizing Addictive Disorders (RAD) scale, which includes seven subscales assessing symptoms related to alcohol use, drug use, tobacco use, gambling, binge‐eating, hypersexual behavior, and excessive video‐gaming. Linear regression and hurdle models identified significant predictors of RAD subscales. Hurdle models included logistic regression estimation for the presence/absence of symptoms and negative binomial regression for estimation of the severity of symptoms.ResultsMost patients did not report significant symptoms beyond drug or tobacco use. However, 7% to 47% of participants reported some symptoms of other addictive behaviors (subscale score > 0). Higher impulsivity predicted the presence and/or increased severity of symptoms of drug use, gambling, binge‐eating, and hypersexuality. Higher depression significantly predicted increased severity of drug use and binge‐eating symptoms. Increased anxiety predicted lower severity of alcohol use and binge‐eating and higher severity of smoking symptoms.Conclusion and Scientific SignificanceA broader range of potentially addictive symptoms may be present among patients engaged in treatment for opioid use disorder. Few studies have assessed symptoms of binge‐eating, hypersexuality, and excessive video‐gaming among patients receiving opioid agonist therapy. This study contributes to preliminary findings and highlights important future directions. (Am J Addict 2021;00:00–00)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021,

title = {Contingency management for individuals with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials},

author = {Jennifer D. Ellis and Cara A. Struble and Marina C. Fodor and Molly Cairncross and Leslie H. Lundahl and David M. Ledgerwood},

doi = {10.1016/j.brat.2020.103781},

issn = {0005-7967},

year  = {2021},

date = {2021-01-00},

journal = {Behaviour Research and Therapy},

volume = {136},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2020b,

title = {Using an Online Platform to Administer the Single-Session Point Subtraction Aggression Paradigm: An Initial Examination of Feasibility and Validity},

author = {Jennifer D. Ellis and Emily R. Grekin and Donald Dekeyser and Ty Partridge},

doi = {10.1177/1073191120940042},

issn = {1552-3489},

year  = {2021},

date = {2021-01-00},

journal = {Assessment},

volume = {28},

number = {1},

pages = {310--321},

publisher = {SAGE Publications},

abstract = { Online platforms represent a cost-effective option for data collection; however, it is unclear whether online administration of certain kinds of tasks (e.g., behavioral measures of aggression) poses validity threats. The present study provided a preliminary examination of effort (as indexed by total number of presses), differential drop-out, and believability of an online version of the single-session point subtraction aggression paradigm (PSAP). Two subsamples of participants were recruited; a sample recruited through Amazon’s Mechanical Turk ( n = 758) and an in-person undergraduate sample ( n = 88). All participants completed the PSAP, along with measures of trait hostility and state anger. The online sample did not differ from the in-person sample on effort (i.e., total number of presses), and did not find the task less believable. Higher scores on state anger were associated with lower likelihood of beginning the online PSAP, but were not associated with prematurely closing the task. State anger was related to aggressive responding on the PSAP. Limitations of the online PSAP and considerations for future research are discussed. },

keywords = {Applied Psychology, Clinical Psychology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2020,

title = {Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States},

author = {Jennifer D. Ellis and Brian P. Pittman and Sherry A. McKee},

doi = {10.1016/j.jsat.2020.108012},

issn = {0740-5472},

year  = {2020},

date = {2020-07-00},

journal = {Journal of Substance Abuse Treatment},

volume = {114},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Pshychiatric Mental Health, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2019,

title = {A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States},

author = {Jamey J. Lister and Addie Weaver and Jennifer D. Ellis and Joseph A. Himle and David M. Ledgerwood},

doi = {10.1080/00952990.2019.1694536},

issn = {1097-9891},

year  = {2020},

date = {2020-05-03},

journal = {The American Journal of Drug and Alcohol Abuse},

volume = {46},

number = {3},

pages = {273--288},

publisher = {Informa UK Limited},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2018,

title = {Client and clinician-rated characteristics of problem gamblers with and without history of gambling-related illegal behaviors},

author = {Jennifer D. Ellis and Jamey J. Lister and Cara A. Struble and Molly Cairncross and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2018.03.017},

issn = {0306-4603},

year  = {2018},

date = {2018-09-00},

journal = {Addictive Behaviors},

volume = {84},

pages = {1--6},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2018b,

title = {Client and clinician-rated characteristics of problem gamblers with and without history of gambling-related illegal behaviors},

author = {Jennifer D. Ellis and Jamey J. Lister and Cara A. Struble and Molly Cairncross and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2018.03.017},

issn = {0306-4603},

year  = {2018},

date = {2018-09-00},

journal = {Addictive Behaviors},

volume = {84},

pages = {1--6},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Hand2017,

title = {Contingency management interventions for tobacco and other substance use disorders in pregnancy.},

author = {Dennis J. Hand and Jennifer D. Ellis and Meagan M. Carr and Diane J. Abatemarco and David M. Ledgerwood},

doi = {10.1037/adb0000291},

issn = {1939-1501},

year  = {2017},

date = {2017-12-00},

journal = {Psychology of Addictive Behaviors},

volume = {31},

number = {8},

pages = {907--921},

publisher = {American Psychological Association (APA)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Rabinowitz2023,

title = {Patterns of demoralization and anhedonia during early substance use disorder treatment and associations with treatment attrition},

author = {Jill A. Rabinowitz and Jennifer D. Ellis and Justin C. Strickland and Martin Hochheimer and Yijun Zhou and Andrea S. Young and Brenda Curtis and Andrew S. Huhn},

doi = {10.1016/j.jad.2023.05.029},

issn = {0165-0327},

year  = {2023},

date = {2023-08-00},

journal = {Journal of Affective Disorders},

volume = {335},

pages = {248--255},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2023d,

title = {Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder},

author = {Jennifer D. Ellis and Jamey J. Lister and Michael J.A. Wohl and Mark K. Greenwald and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2022.107604},

issn = {0306-4603},

year  = {2023},

date = {2023-05-00},

journal = {Addictive Behaviors},

volume = {140},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2022b,

title = {Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use},

author = {Jennifer D. Ellis and Jill A. Rabinowitz and Jonathan Wells and Fangyu Liu and Patrick H. Finan and Michael D. Stein and Denis G. Antoine II and Gregory J. Hobelmann and Andrew S. Huhn},

doi = {10.1016/j.jad.2021.12.004},

issn = {0165-0327},

year  = {2022},

date = {2022-02-00},

journal = {Journal of Affective Disorders},

volume = {299},

pages = {223--232},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021b,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021c,

title = {Clinical correlates of drug‐related dreams in opioid use disorder},

author = {Jennifer D. Ellis and Jami L. Mayo and Patrick H. Finan and Charlene E. Gamaldo and Andrew S. Huhn},

doi = {10.1111/ajad.13219},

issn = {1521-0391},

year  = {2022},

date = {2022-01-00},

journal = {American J Addict},

volume = {31},

number = {1},

pages = {37--45},

publisher = {Wiley},

abstract = {AbstractBackground and ObjectivesDrug‐related dreams are commonly reported by individuals in treatment for substance use disorders, which may be distressing. Existing evidence suggests that dream recollection may be influenced by clinically relevant phenomena, such as opioid use and withdrawal, general sleep disturbance, affective symptoms, and chronic pain. However, very few studies have explored drug‐related dreams among individuals who screened positive for opioid use disorder (OUD).MethodsAdults recruited from Amazon Mechanical Turk (MTurk) who screened positive for OUD (N = 154) completed a questionnaire about drug‐related dreams, as well as measures assessing sleep, opioid use history, stress, anxiety, and chronic pain. χ2 analyses, one‐way analysis of variance, and bivariate correlations, correcting for the false discovery rate, were used as appropriate to explore correlates of (1) recollecting a drug‐related dream, and (2) experiencing post‐dream craving and distress.ResultsIndividuals who recollected a past‐week drug‐related dream were more likely to report other recent sleep disturbances, including poorer sleep quality, greater insomnia symptoms, and a higher risk for sleep apnea. Post‐dream craving and distress were both associated with greater insomnia symptoms, poor sleep hygiene behaviors, and greater anxiety symptoms. Individuals who had ever experienced a drug‐related dream (recently, or in their lifetime) were more likely to report a history of severe withdrawal, overdose, and intravenous opioid use.Conclusion and Scientific SignificanceDrug‐related dreams were common among individuals in the present sample and were related to other clinically relevant phenomena. Interventions that treat co‐occurring OUD, pain, sleep symptoms, and affective symptoms may improve overall well‐being in this population.},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Carr2021,

title = {Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies},

author = {Meagan M. Carr and Jennifer D. Ellis and Karen K. Saules and Jamie L. Page and Angela Staples and David M. Ledgerwood},

doi = {10.1111/ajad.13149},

issn = {1521-0391},

year  = {2021},

date = {2021-07-00},

journal = {American J Addict},

volume = {30},

number = {4},

pages = {343--350},

publisher = {Wiley},

abstract = {Background and ObjectivesPatients receiving opioid agonist therapies have high rates of psychiatric comorbidity. Some data suggest that comorbidity is associated with poorer treatment outcomes. The current study assessed predictors of multiple putative addictive behaviors among patients receiving opioid agonist therapies.MethodsAdults (N = 176) recruited from an outpatient clinic providing opioid agonist therapy completed self‐report measures of depression, anxiety, impulsivity, adverse childhood events, and the Recognizing Addictive Disorders (RAD) scale, which includes seven subscales assessing symptoms related to alcohol use, drug use, tobacco use, gambling, binge‐eating, hypersexual behavior, and excessive video‐gaming. Linear regression and hurdle models identified significant predictors of RAD subscales. Hurdle models included logistic regression estimation for the presence/absence of symptoms and negative binomial regression for estimation of the severity of symptoms.ResultsMost patients did not report significant symptoms beyond drug or tobacco use. However, 7% to 47% of participants reported some symptoms of other addictive behaviors (subscale score > 0). Higher impulsivity predicted the presence and/or increased severity of symptoms of drug use, gambling, binge‐eating, and hypersexuality. Higher depression significantly predicted increased severity of drug use and binge‐eating symptoms. Increased anxiety predicted lower severity of alcohol use and binge‐eating and higher severity of smoking symptoms.Conclusion and Scientific SignificanceA broader range of potentially addictive symptoms may be present among patients engaged in treatment for opioid use disorder. Few studies have assessed symptoms of binge‐eating, hypersexuality, and excessive video‐gaming among patients receiving opioid agonist therapy. This study contributes to preliminary findings and highlights important future directions. (Am J Addict 2021;00:00–00)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2021,

title = {Contingency management for individuals with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials},

author = {Jennifer D. Ellis and Cara A. Struble and Marina C. Fodor and Molly Cairncross and Leslie H. Lundahl and David M. Ledgerwood},

doi = {10.1016/j.brat.2020.103781},

issn = {0005-7967},

year  = {2021},

date = {2021-01-00},

journal = {Behaviour Research and Therapy},

volume = {136},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2020b,

title = {Using an Online Platform to Administer the Single-Session Point Subtraction Aggression Paradigm: An Initial Examination of Feasibility and Validity},

author = {Jennifer D. Ellis and Emily R. Grekin and Donald Dekeyser and Ty Partridge},

doi = {10.1177/1073191120940042},

issn = {1552-3489},

year  = {2021},

date = {2021-01-00},

journal = {Assessment},

volume = {28},

number = {1},

pages = {310--321},

publisher = {SAGE Publications},

abstract = { Online platforms represent a cost-effective option for data collection; however, it is unclear whether online administration of certain kinds of tasks (e.g., behavioral measures of aggression) poses validity threats. The present study provided a preliminary examination of effort (as indexed by total number of presses), differential drop-out, and believability of an online version of the single-session point subtraction aggression paradigm (PSAP). Two subsamples of participants were recruited; a sample recruited through Amazon’s Mechanical Turk ( n = 758) and an in-person undergraduate sample ( n = 88). All participants completed the PSAP, along with measures of trait hostility and state anger. The online sample did not differ from the in-person sample on effort (i.e., total number of presses), and did not find the task less believable. Higher scores on state anger were associated with lower likelihood of beginning the online PSAP, but were not associated with prematurely closing the task. State anger was related to aggressive responding on the PSAP. Limitations of the online PSAP and considerations for future research are discussed. },

keywords = {Applied Psychology, Clinical Psychology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2020,

title = {Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States},

author = {Jennifer D. Ellis and Brian P. Pittman and Sherry A. McKee},

doi = {10.1016/j.jsat.2020.108012},

issn = {0740-5472},

year  = {2020},

date = {2020-07-00},

journal = {Journal of Substance Abuse Treatment},

volume = {114},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Pshychiatric Mental Health, Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Lister2019,

title = {A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States},

author = {Jamey J. Lister and Addie Weaver and Jennifer D. Ellis and Joseph A. Himle and David M. Ledgerwood},

doi = {10.1080/00952990.2019.1694536},

issn = {1097-9891},

year  = {2020},

date = {2020-05-03},

journal = {The American Journal of Drug and Alcohol Abuse},

volume = {46},

number = {3},

pages = {273--288},

publisher = {Informa UK Limited},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2018,

title = {Client and clinician-rated characteristics of problem gamblers with and without history of gambling-related illegal behaviors},

author = {Jennifer D. Ellis and Jamey J. Lister and Cara A. Struble and Molly Cairncross and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2018.03.017},

issn = {0306-4603},

year  = {2018},

date = {2018-09-00},

journal = {Addictive Behaviors},

volume = {84},

pages = {1--6},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Ellis2018b,

title = {Client and clinician-rated characteristics of problem gamblers with and without history of gambling-related illegal behaviors},

author = {Jennifer D. Ellis and Jamey J. Lister and Cara A. Struble and Molly Cairncross and Meagan M. Carr and David M. Ledgerwood},

doi = {10.1016/j.addbeh.2018.03.017},

issn = {0306-4603},

year  = {2018},

date = {2018-09-00},

journal = {Addictive Behaviors},

volume = {84},

pages = {1--6},

publisher = {Elsevier BV},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health, Toxicology},

pubstate = {published},

tppubtype = {article}

}

@article{Hand2017,

title = {Contingency management interventions for tobacco and other substance use disorders in pregnancy.},

author = {Dennis J. Hand and Jennifer D. Ellis and Meagan M. Carr and Diane J. Abatemarco and David M. Ledgerwood},

doi = {10.1037/adb0000291},

issn = {1939-1501},

year  = {2017},

date = {2017-12-00},

journal = {Psychology of Addictive Behaviors},

volume = {31},

number = {8},

pages = {907--921},

publisher = {American Psychological Association (APA)},

keywords = {Clinical Psychology, Medicine (miscellaneous), Psychiatry and Mental health},

pubstate = {published},

tppubtype = {article}

}